These components synergistically regulate the AMPK and PI3K/Akt signaling pathways via SIRT1/PTGS2/PKCA cross-talk, thereby targeting both ferroptosis and anoikis in cardiac and renal cells to combat CRS. Here, PTGS2 is linked to congenital rubella syndrome.